Biotech · Private company
Elios Therapeutics, LLC
Track this companyFree. Adds Elios Therapeutics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- TLPLDCPhase 2 · MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- TLPLDC VaccinePhase 2 · Metastatic MelanomaClinicalTrials.gov · fetched Nov 12, 2026
- Tumor lysate, particle only (TLPO) vaccinePhase 2 · Tumor, SolidClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Autologous TLPO Vaccine BasketPHASE2 · TERMINATED · started Nov 29, 2023ClinicalTrials.gov NCT06175221 · fetched Nov 12, 2026
- Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.PHASE1_PHASE2 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02678741 · fetched Nov 12, 2026
- Phase IIB TL + YCWP + DC in MelanomaPHASE2 · COMPLETED · started Jan 1, 2015ClinicalTrials.gov NCT02301611 · fetched Nov 12, 2026